NICE (UK) recommends Joenja (leniolisib) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over – Pharming
NICE (UK): Leniolisib is recommended, within its marketing authorisation, for treating activated phosphoinositide 3‑kinase delta syndrome (APDS) in people 12 years and over. Leniolisib is recommended only if the… read more.
